Skip to main content
OpenTrials
Completed

NCT Number: NCT05150028

A Virtual Intervention to Improve Medication Adherence in Pediatric Cancer: MedSupport

To develop a cancer center level practice intervention to promote treatment adherence and reduce outcome disparities in pediatric cancer survivors

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Medication Adherence Behavior Health Behavior Patient Acceptance of Health Care Patient Compliance Treatment Adherence and Compliance

Age range

1 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Roswell Park Cancer Institute

Buffalo, New York, 14263, United States

About this study

To conduct a pilot study to assess the feasibility and acceptability of the Social Determinants of Adherence intervention

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Parents/caregivers of pediatric patients must meet the following criteria to be eligible:

  • Parents/guardians of child that has been diagnosed with any cancer.
  • Parents/guardians of child with any cancer between age 0 and 18.
  • Parents/guardians of child on home-based oral anti-cancer therapy or supportive care therapy.
  • The clinician for the family agrees to participate in the study.

Exclusion criteria

  • Participants will be excluded from this study if unwilling or unable to complete the assessment in English

Treatment and study plan

Patient participation

Behavioral

Questionnaire

Clinician barrier reports

Other

How many times a 7 question Survey on medication education practices is opened

Primary outcomes

  1. Retention rates

    Time frame: Up to 8 weeks

    Feasibility of intervention as assessed by retention rates

Secondary outcomes

  1. Feasibility of universal SDOA screening

    Time frame: up to 8 weeks

    Will be assessed by results of SDOA questionnaire an 8 item questionnaire rated on a 5-point Likert scale (0-I never experienced this ; 5 - I experience this quite a lot)

  2. Provider satisfaction with barrier reports

    Time frame: up to 8 weeks

    REDCap analytics will track the rate of opened barrier reports

Sponsors and collaborators

Lead sponsor

Roswell Park Cancer Institute

Other

Registry information

Important dates

Study start
2023
Primary completion
2023
Study completion
2024
First posted
Dec 8, 2021
Registry last updated
Sep 19, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.